Alexandre Calon

[Alexandre Calon @Calon_Alex]

📢 Our paper is out!

We define CTHRC1-CAFs as #biomarker of response to #immunotherapy in MSS and MSI #CRC

Great teamwork @CalonLab @BatlleLab @mariglesiascoma

Thanks @ContraCancerEs for their support

🔗 https://t.co/46HjvMjvXu

[Alexandre Calon @Calon_Alex]

https://t.co/C9phfjEY4x

[Alexandre Calon @Calon_Alex]

📢 Our paper is out!

We define CTHRC1-CAFs as #biomarker of response to #immunotherapy in MSS and MSI #CRC

Great teamwork @CalonLab @BatlleLab @mariglesiascoma

Thanks @ContraCancerEs for their support

🔗 https://t.co/46HjvMjvXu

[Hospital del Mar @hospitaldelmar]

🔬What if we could predict who will respond to immunotherapy in colorectal cancer?
🧬New biomarker (CTHRC1) led by @Calon_Alex @HMar_research & @BatlleLab @IRBBarcelona
👩‍⚕️With @ClaraMontagut & @mariglesiascoma
📊Read the full article: https://t.co/5bAZxLvvTR
@hmarpath @CIBER_ISCIII

[HMar Research Institute @HMar_research]

🔬CTHRC1 identified as key biomarker in colorectal cancer
🧬Led by @Calon_Alex @HMar_research & @BatlleLab @IRBBarcelona
📊Validated in ~3,000 patients
🧪With @ClaraMontagut & @mariglesiascoma
👉Study: https://t.co/K0NnJi4vEo
@hmarpath @CIBER_ISCIII

[CalonLab @CalonLab]

📢 Published in @Gut_BMJ! We define CTHRC1-CAFs as a #biomarker of clinical outcome and response to #immunotherapy in MSS and MSI #colorectal #cancer.

https://t.co/2kl6t2V1p5

@mariglesiascoma @Calon_Alex @BatlleLab @ClaraMontagut @hospitaldelmar @HMar_research @IRBBarcelona

[HMar Research Institute @HMar_research]

La revista @Nature selecciona un estudi liderat per
@PNavarro_Lab com un dels sis més destacats de l’any en #càncerdepàncrees

👉https://t.co/rGeQfzYTsU

#TalentMAR
@CancerCSIC @iibbcsic

[HMar Research Institute @HMar_research]

La Fundació ”la Caixa” atorga una ajuda a un projecte liderat pel Dr. @Calon_Alex

Un projecte per avançar en el coneixement de l'entorn tumoral en #càncercòlon i recte

@CanalUGR @uniovi_info @cnag_eu #HealthResearch #FundaciólaCaixa

https://t.co/zdYA0UglF9

[CNAG @cnag_eu]

⭐️La Fundació ”la Caixa” atorga una ajuda de prop 1M€ per a un projecte de càncer de còlon amb participació del CNAG!

La iniciativa està liderada pel Dr. @Calon_Alex (@HMar_research), amb suport d'organismes com @CanalUGR i @uniovi_info

https://t.co/aJP7wRXygr
#FundaciólaCaixa

[Hospital del Mar @hospitaldelmar]

La Fundación ”la Caixa” otorga una ayuda a un proyecto liderado por el Dr. @Calon_Alex

Pretende avanzar en el conocimiento del entorno tumoral en #cáncercolon y recto

@CanalUGR @uniovi_info @cnag_eu @CaixaResearchCA #HealthResearch #FundaciónlaCaixa

https://t.co/eob470yz7W

[Alexandre Calon @Calon_Alex]

https://t.co/lKL9Dw561L

#HealthResearch #FundaciónlaCaixa

[Alexandre Calon @Calon_Alex]

💡Chemists, physicists, biologists, clinicians, and computational scientists — 4 teams, one vision: bringing new hope to people facing colorectal cancer.

Thanks to @FundlaCaixa / Health Research Call 2025.

@CanalUGR @uniovi_info @cnag_eu @CaixaResearch @HMar_research

[ASEICA @ASEICAnews]

⚫Si eres médico e investigas en cáncer, ASEICA-Med es tu comunidad

📽️Te lo cuenta @JLinaresA (@hospitaldelmar)

Te esperamos en el RETREAT #ASEICAMed
📅7OCT
🏟️Bilbao-San Mames
‼️ Posibilidad de Registro único o a todo el #ASEICACongress

https://t.co/MSOKt3h4jw

[Noelia Tarazona @TarazonaNoelia]

🔥Just out in @NatureCancer!

✅ TAV16, our tumor-agnostic WES-based assay, ranks among the best for MRD detection.
✅ Immune evasion as the main driver progression in MSS CRC, opening new avenues for ICIs.

🙏@_SEOM @GrupoTTD @SaludISCIII @GVAclinic

https://t.co/iWuJuIQzDp

[CSIC @CSIC]

🧑‍🔬Identifican un nuevo factor que determina la agresividad del cáncer de páncreas

👩‍🔬Equipos del @iibbcsic y el @HMar_research demuestran el papel clave de una proteína en el núcleo de las células que rodean el tumor

👉 https://t.co/0JBSxOYGdn

[Pilar Navarro Lab @PNavarro_Lab]

🚨 We'are thrilled to share our last study in colab with @gabyrabi, Juan L. Iovanna & @MFZlab that reveals a nuclear role for Galectin-1 (Gal1) in pancreatic stellate cells (PSCs), directly regulating KRAS expression and reshaping the PDAC stroma. A thread! 🧵👇
@PNASNews #PDAC

[Hospital del Mar @hospitaldelmar]

Les ajudes a la #recerca de @ContraCancerBCN han seleccionat 3 projectes de @HMar_research, liderats per Lluís Espinosa, @JLinaresA i @ClaraMontagut

També un projecte @IRBBarcelona amb participació de la Dra. @SoniaServitja

#CancerResearch #TalentMAR

https://t.co/CpbbGR8vLd

[Alexandre Calon @Calon_Alex]

🚨 New publication from our lab! A fantastic collaboration between @HMar_research and @IBECBarcelona

[CalonLab @CalonLab]

Paper alert! 📢 With the @XavierTrepat lab, we have developed MIRO, an #invitro platform to recreate #Cancer cells interactions with their microenvironment to test new #Immunotherapy strategies.

https://t.co/yE3arQDOO3
@HMar_research @hospitaldelmar @IBECBarcelona @NatureComms

[CalonLab @CalonLab]

Paper alert! 📢 With the @XavierTrepat lab, we have developed MIRO, an #invitro platform to recreate #Cancer cells interactions with their microenvironment to test new #Immunotherapy strategies.

https://t.co/yE3arQDOO3
@HMar_research @hospitaldelmar @IBECBarcelona @NatureComms

[Hospital del Mar @hospitaldelmar]

El Dr. @Calon_Alex explica la #recerca que ha permès crear #MIRO, dispositiu que replica els #tumors per estudiar l’eficàcia de la #immunoteràpia

Treball amb @IBECBarcelona i @CIPFciencia que publica @NatureComms

#oncologia #càncer #recerca

https://t.co/YtSglQk7uT